Lataa...
Risk of breast cancer after stopping menopausal hormone therapy in the E3N cohort
PURPOSE: Questions remain on how the excess risk of breast cancer associated with menopausal hormone therapy (MHT) evolves after treatment stops. METHODS: We investigated that issue in the E3N cohort, with 3678 invasive breast cancers identified between 1992 and 2008 among 78 353 women (881 290 pers...
Tallennettuna:
| Julkaisussa: | Breast Cancer Res Treat |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Kluwer Academic
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5924370/ https://ncbi.nlm.nih.gov/pubmed/24781971 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-014-2934-6 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|